The jury returned a verdict in the New Jersey Vioxx trial yesterday afternoon.
The jury found that Merck had failed to warn the men about the risks of heart attack and stroke associated with Vioxx but found a causal link between the drug and a heart attack for only one plaintiff.
McDarby, who said he used the drug for four years, was awarded $3.0 million. His wife was awarded $1.5 million.
The New Jersey Vioxx case is to the jury – the defense did its closing argument yesterday.
Also, here is an interesting article about jury questions in the Vioxx case.
Litigation against paint manufacturers for using lead in paint has been underway for years and the industry has always won.
Until now.
Here is a fascinating story about lead paint litigation in Rhode Island and the recent jury verdict for the State of Rhode Island after more than five months of trial. It includes juror interviews.
The defense in the New Jersey Vioxx case has rested. Read more here.
The end is near in the New Jersey Vioxx trial. Here is the latest.
More proof from the defense in the New Jersey Vioxx trial; read about it here.
The next federal Vioxx trial begins June 12, 2006.
The trial of the Vioxx cases in New Jersey is winding down. Here is a recent update.
The defense starts it case in the New Jersey Vioxx trial. The trial is expected to be over next week.
Motion for directed verdict denied. Merck has now begun to offer its defense to the two Vioxx cases consolidated for trial in New Jersey. Read more here.
Meanwhile, the California Vioxx cases are heating up. Learn more here.
The Supreme Court denied cert in a cigarette case yesterday, letting a $50,000,000 punitive damages award stand against Phillip Morris. The compensatory damages in the case were $5,500,000.
This will be an encouragement to the plaintiff in the Oregon tobacco case; recall that the Oregon Supreme Court affirmed a $79.5 million punitive damage verdict for that plaintiff recently.
Read more here.
Day on Torts